Carrier protein outsourcing: A new paradigm for rapidly translating novel conjugate vaccines into the clinic

BioProcess International

Volumn 10, Issue 10, 2012, Pages 50-55

  Brady, Cassidy ^a   Killeen, Kevin ^b   Taylor, William ^a   Patkar, Anant ^a   Lees, Andy ^c  

^a Pfenex Inc   (United States)

^b Matrivax RandD Corp   (United States)

^c Fina Biosolutions LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; DIPHTHERIA TOXOID; DIPHTHERIA TOXOID CRM197; KEYHOLE LIMPET HEMOCYANIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TETANUS TOXOID; VACCINE;

CORYNEBACTERIUM DIPHTHERIAE; DIPHTHERIA; DRUG INDUSTRY; GOOD MANUFACTURING PRACTICE; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH CARE DELIVERY; HELPER CELL; HUMAN; IMMUNOGENICITY; NEISSERIA MENINGITIDIS; PRODUCT DEVELOPMENT; PSEUDOMONAS FLUORESCENS; SALMONELLA ENTERICA; SHORT SURVEY; STREPTOCOCCUS PNEUMONIAE;

EID: 84870233804     PISSN: 15426319     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Short Survey

References (8)

1. Medicines in Development: Vaccines. PhRMA 2012 Report; www.phrma.org/research/new-medicines.
2. Jarvis A. Strengthening Leadership in Developed and Emerging Markets. 2011 World Vaccine Congress Meeting. 16-18 October 2011, Lyon, France.
3. Jennings HJ, Pon RA. Bacterial Polysaccharide Vaccines: Glycoconjugates and Peptide-Mimetics. Microbial Glycobiology. Elsevier Inc.: Maryland Heights, MO, 2009.
4. Knuf M, Kowalzik F, Kieninger D. Comparative Effects of Carrier Proteins on Vaccine-Induced Immune Response. Vaccine 29(31) 2011: 4881-4890.
5. Broker M, et al. Biochemical and Biological Characteristics of Cross-Reacting Material 197 (CRM197), a Nontoxic Mutant of Diphtheria Toxin. Biologicals 39(4) 2011: 195-204.
6. Wolfe H, et al. Process for Production of Diphtheria Toxin. United States Patent 7575891.
7. Retallack DM, Jin H, Chew L. Reliable Protein Production in a Pseudomonas fluorescens Expression System. Protein Expr. Purif. 2012 81(2) 2012: 157-165.
8. Levine HL. Vaccine Manufacturing in the Coming Decade. World Vaccines Manufacturing Congress. 16-18 October 2011, Lyon, France.